Leuprorelin and Triptorelin in the treatment of Prostate Cancer: Medication adherence, Persistence and Economic Evaluation in Five Years of Analysis : Figure 1

Figure 1: Persistence for Leuprorelin and Triptorelin in the treatment of prostate cancer for four years.